Nanomedicine and nanotechnology delivery systems are relatively new but have shown promising results and potential for innovative new drugs.

In this Insight Article, we delve into the complex intricacies of the Blood-Brain Barrier, explore its challenge for drug delivery, and look at 3 of the most exciting solution technologies.

Innovative drug delivery systems create a new paradigm for pharmaceuticals, enabling more efficient and targeted administration.

Presented by Alison Foster, Head of Technical – Pre-Clinical, Quay Pharma & Mike Frodsham, Chief Technical Officer, Quay Pharma

Hovik Gukasyan, Associate Director, Early Pharmaceutical Development, Allergan plc

Stefan Grudén, Director of Pharmaceutical R&D, Lidds Pharma

Jonas Fransson, Director of Drug Product Development, Sobi AB

Kamalinder K Singh, Shilpa Pawar, Jane Elizabeth Alder, School of Pharmacy and Biomedical Sciences, Faculty of Clinical and Biomedical Sciences, University of Central Lancashire

Maya Thanou, Reader, King's College London

Luis Padrela, Kevin M Ryan, Barry Long, Luis Padrela: Lecturer in Bioprocess Engineering, Bernal Institute; Kevin M Ryan: Chair in Chemical Nanotechnology, Bernal Institute; Barry Long: PhD student working in the design of supercritical fluid methods for the continuous manufacture of pharmaceutical nanocrystals, University of Limerick